139 related articles for article (PubMed ID: 18261904)
1. Novel non-peptidic and small-sized BACE1 inhibitors.
Hamada Y; Ohta H; Miyamoto N; Yamaguchi R; Yamani A; Hidaka K; Kimura T; Saito K; Hayashi Y; Ishiura S; Kiso Y
Bioorg Med Chem Lett; 2008 Mar; 18(5):1643-7. PubMed ID: 18261904
[TBL] [Abstract][Full Text] [Related]
2. Significance of interactions of BACE1-Arg235 with its ligands and design of BACE1 inhibitors with P2 pyridine scaffold.
Hamada Y; Ohta H; Miyamoto N; Sarma D; Hamada T; Nakanishi T; Yamasaki M; Yamani A; Ishiura S; Kiso Y
Bioorg Med Chem Lett; 2009 May; 19(9):2435-9. PubMed ID: 19345096
[TBL] [Abstract][Full Text] [Related]
3. BACE1 inhibitors: optimization by replacing the P1' residue with non-acidic moiety.
Hamada Y; Abdel-Rahman H; Yamani A; Nguyen JT; Stochaj M; Hidaka K; Kimura T; Hayashi Y; Saito K; Ishiura S; Kiso Y
Bioorg Med Chem Lett; 2008 Mar; 18(5):1649-53. PubMed ID: 18249539
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship study of BACE1 inhibitors possessing a chelidonic or 2,6-pyridinedicarboxylic scaffold at the P(2) position.
Hamada Y; Suzuki K; Nakanishi T; Sarma D; Ohta H; Yamaguchi R; Yamasaki M; Hidaka K; Ishiura S; Kiso Y
Bioorg Med Chem Lett; 2014 Jan; 24(2):618-23. PubMed ID: 24360554
[TBL] [Abstract][Full Text] [Related]
5. Novel BACE1 inhibitors possessing a 5-nitroisophthalic scaffold at the P2 position.
Hamada Y; Nakanishi T; Suzuki K; Yamaguchi R; Hamada T; Hidaka K; Ishiura S; Kiso Y
Bioorg Med Chem Lett; 2012 Jul; 22(14):4640-4. PubMed ID: 22726930
[TBL] [Abstract][Full Text] [Related]
6. Tripeptidic BACE1 inhibitors devised by in-silico conformational structure-based design.
Hamada Y; Tagad HD; Nishimura Y; Ishiura S; Kiso Y
Bioorg Med Chem Lett; 2012 Jan; 22(2):1130-5. PubMed ID: 22178553
[TBL] [Abstract][Full Text] [Related]
7. Design of pentapeptidic BACE1 inhibitors with carboxylic acid bioisosteres at P1' and P4 positions.
Tagad HD; Hamada Y; Nguyen JT; Hamada T; Abdel-Rahman H; Yamani A; Nagamine A; Ikari H; Igawa N; Hidaka K; Sohma Y; Kimura T; Kiso Y
Bioorg Med Chem; 2010 May; 18(9):3175-86. PubMed ID: 20381362
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of potent beta-secretase (BACE1) inhibitors with P1' carboxylic acid bioisosteres.
Kimura T; Hamada Y; Stochaj M; Ikari H; Nagamine A; Abdel-Rahman H; Igawa N; Hidaka K; Nguyen JT; Saito K; Hayashi Y; Kiso Y
Bioorg Med Chem Lett; 2006 May; 16(9):2380-6. PubMed ID: 16481167
[TBL] [Abstract][Full Text] [Related]
9. Tetrapeptides, as small-sized peptidic inhibitors; synthesis and their inhibitory activity against BACE1.
Kakizawa T; Hidaka K; Hamada D; Yamaguchi R; Uemura T; Kitamura H; Tagad HD; Hamada T; Ziora Z; Hamada Y; Kimura T; Kiso Y
J Pept Sci; 2010 Jun; 16(6):257-62. PubMed ID: 20474036
[TBL] [Abstract][Full Text] [Related]
10. KMI-358 and KMI-370, highly potent and small-sized BACE1 inhibitors containing phenylnorstatine.
Kimura T; Shuto D; Kasai S; Liu P; Hidaka K; Hamada T; Hayashi Y; Hattori C; Asai M; Kitazume S; Saido TC; Ishiura S; Kiso Y
Bioorg Med Chem Lett; 2004 Mar; 14(6):1527-31. PubMed ID: 15006396
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of highly active Alzheimer's beta-secretase (BACE1) inhibitors, KMI-420 and KMI-429, with enhanced chemical stability.
Kimura T; Shuto D; Hamada Y; Igawa N; Kasai S; Liu P; Hidaka K; Hamada T; Hayashi Y; Kiso Y
Bioorg Med Chem Lett; 2005 Jan; 15(1):211-5. PubMed ID: 15582441
[TBL] [Abstract][Full Text] [Related]
12. Boom in the development of non-peptidic beta-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease.
Silvestri R
Med Res Rev; 2009 Mar; 29(2):295-338. PubMed ID: 18651582
[TBL] [Abstract][Full Text] [Related]
13. Structure-guided design and synthesis of P1' position 1-phenylcycloalkylamine-derived pentapeptidic BACE1 inhibitors.
Tagad HD; Hamada Y; Nguyen JT; Hidaka K; Hamada T; Sohma Y; Kimura T; Kiso Y
Bioorg Med Chem; 2011 Sep; 19(17):5238-46. PubMed ID: 21803585
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
[TBL] [Abstract][Full Text] [Related]
15. Novel BACE1 inhibitors with a non-acidic heterocycle at the P1' position.
Suzuki K; Hamada Y; Nguyen JT; Kiso Y
Bioorg Med Chem; 2013 Nov; 21(21):6665-73. PubMed ID: 23993670
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of BACE1 inhibitors containing a novel norstatine derivative (2R,3R)-3-amino-2-hydroxy-4-(phenylthio)butyric acid.
Ziora Z; Kasai S; Hidaka K; Nagamine A; Kimura T; Hayashi Y; Kiso Y
Bioorg Med Chem Lett; 2007 Mar; 17(6):1629-33. PubMed ID: 17251016
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of 5,5'-disubstituted aminohydantoins as potent and selective human beta-secretase (BACE1) inhibitors.
Malamas MS; Erdei J; Gunawan I; Turner J; Hu Y; Wagner E; Fan K; Chopra R; Olland A; Bard J; Jacobsen S; Magolda RL; Pangalos M; Robichaud AJ
J Med Chem; 2010 Feb; 53(3):1146-58. PubMed ID: 19968289
[TBL] [Abstract][Full Text] [Related]
18. Prolonged stability by cyclization: Macrocyclic phosphino dipeptide isostere inhibitors of beta-secretase (BACE1).
Huber T; Manzenrieder F; Kuttruff CA; Dorner-Ciossek C; Kessler H
Bioorg Med Chem Lett; 2009 Aug; 19(15):4427-31. PubMed ID: 19523824
[TBL] [Abstract][Full Text] [Related]
19. beta-Secretase inhibitors: modification at the P4 position and improvement of inhibitory activity in cultured cells.
Hamada Y; Igawa N; Ikari H; Ziora Z; Nguyen JT; Yamani A; Hidaka K; Kimura T; Saito K; Hayashi Y; Ebina M; Ishiura S; Kiso Y
Bioorg Med Chem Lett; 2006 Aug; 16(16):4354-9. PubMed ID: 16757166
[TBL] [Abstract][Full Text] [Related]
20. KMI-008, a novel beta-secretase inhibitor containing a hydroxymethylcarbonyl isostere as a transition-state mimic: design and synthesis of substrate-based octapeptides.
Shuto D; Kasai S; Kimura T; Liu P; Hidaka K; Hamada T; Shibakawa S; Hayashi Y; Hattori C; Szabo B; Ishiura S; Kiso Y
Bioorg Med Chem Lett; 2003 Dec; 13(24):4273-6. PubMed ID: 14643307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
